Back to Search Start Over

Use of propranolol for parotid hemangioma.

Authors :
Chang, Lei
Jin, Yunbo
Lv, Dongze
Ying, Hanru
Wang, Tianyou
Qiu, Yajing
Ma, Gang
Chen, Hui
Yu, Wenxin
Yang, Xi
Lin, Xiaoxi
Source :
Head & Neck; Apr2016 Supplement, Vol. 38, pE1730-E1736, 7p
Publication Year :
2016

Abstract

Background Few specific reports have addressed propranolol as a treatment for parotid hemangioma, and its mechanism remains unclear. Methods Eighty-seven patients were recruited in this prospective study. Ten patients underwent detailed color Doppler examination. The depths, vessel densities, and resistant indices of 10 lesions were recorded and analyzed before treatment and at 1 and 3 months after treatment. Results The overall responses were 'bad' in 2 cases, 'stable' in 4 cases, 'good' in 53 cases, and 'excellent' in 28 cases. Hemangioma regrowth was observed in 11 cases (12.6%). The parents of 18 patients (20.7%) complained that their children experienced minor discomfort during therapy. The lesion depths, vessel densities, and resistant indices were altered after propranolol treatment. Conclusion Propranolol can significantly reduce the sizes of parotid hemangiomas with minor side effects. Hemodynamic changes might play an important role in the course of propranolol treatment. © 2015 Wiley Periodicals, Inc. Head Neck 38: E1730-E1736, 2016 [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
10433074
Volume :
38
Database :
Complementary Index
Journal :
Head & Neck
Publication Type :
Academic Journal
Accession number :
114816250
Full Text :
https://doi.org/10.1002/hed.24308